Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
IVI Announces Six New Members to Board of Directors
IVI, the research-based non-profit organization improving the science and practice of value assessment, unveils six new members to its Board of Directors. - January 30, 2020 - Innovation and Value Initiative
MedBiome Licenses the RapidAIM Technology Targeting the Microbiome to Improve Human Health
MedBiome accelerates the development of drugs targeting the gut microbiome. The RapidAIM technology enables rapid screening of the effects of compounds on live individual human microbiomes in 96 well plates. - January 30, 2020 - MedBiome
Spine Care Technologies Inc. and Zober Industries Inc. Announce Strategic Alliance
Spine Care Technologies Inc., headquartered in Hauppauge, New York, is pleased to announce its new strategic alliance with Zober Industries, a one-stop source for custom manufacturing and assembly. Located in Croydon, Pennsylvania, Zober has been in business for 50 years and they currently operate... - January 27, 2020 - Spine Care Technologies
Spine Care Technologies Inc. to Attend Arab Health2020 in Dubai, UAE
Announcement about Spine Care Technologies' participation in the Arab Health2020 Exhibition in Dubai. - January 27, 2020 - Spine Care Technologies
HCA Healthcare/HealthONE’s Sarah Cannon Cancer Institute at Swedish Medical Center Named National Pancreas Foundation Center of Excellence
Sarah Cannon Cancer Institute at Swedish Medical Center has been named a National Pancreas Foundation Center of Excellence for Pancreatic Cancer, a designation awarded to premier healthcare facilities that focus on multidisciplinary treatment of pancreas cancer. Swedish is one of only two facilities in Colorado to receive the prestigious designation from the National Pancreas Foundation. - January 26, 2020 - Swedish Medical Center
The Pediatric Cancer Research Foundation Funds 6 New Research Grants in 2020
The Pediatric Cancer Research Foundation (PCRF) is proud to award 6 new grants with a total of 18 grants in 2020. These new grants are comprised of three Basic Science, one Translational and three Emerging Research grants totaling $675,000. With these new additions, PCRF will fund over $2.2 million... - January 25, 2020 - Pediatric Cancer Research Foundation
ALS Therapy Development Institute Announces Naming of Augie’s Quest Translational Research Center
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
Michael Montesi, MD, Located in Cleveland, Mississippi, is Elevating His Practice by Partnering with Simpatra.Health
Michael Montesi, MD, will be adding Simpatra.Health’s BHRT services and technology to his practice. - January 10, 2020 - Simpatra
GenInvo Launch
GenInvo launches to provide innovative and transformative solutions to the pharma industry to help bring life-changing treatments to patients faster. - December 23, 2019 - GenInvo, Inc.
HCA Healthcare/HealthONE's Swedish Medical Center Performs First Robotic Minimally Invasive Brain Procedure for Epilepsy
Epilepsy patients looking for minimally invasive procedures for brain surgery now have a new option at Swedish Medical Center’s level 4 epilepsy center. - December 21, 2019 - Swedish Medical Center
MITA Commends Senate Lawmakers for Voting to Repeal Device Tax as Part of End-of-Year Spending Package
The Medical Imaging & Technology Alliance (MITA) today commended Senate lawmakers for approving a provision to permanently repeal the medical device tax in the year-end spending agreement recently passed by the House of Representatives. Immediately after the vote, Dennis Durmis, SVP –... - December 19, 2019 - Medical Imaging and Technology Alliance
ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring Former NFL Player Tim Shaw “The Age of A.I.” Hosted by Robert Downey Jr.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes... - December 18, 2019 - ALS Therapy Development Institute
A Bestselling New Release in Neuroscience on Amazon.com Explaining the Origin of Consciousness Receives Praise and Push-Back
Citing research conducted at eleven different universities, the author of a new book entitled, “Consciousness, The Hard Problem Solved,” reveals what he believes is the origin of consciousness and is both praised and ridiculed as a result. - December 18, 2019 - The Oaklea Press
MITA Commends Lawmakers for Bipartisan Agreement to Include Permanent Repeal of Device Tax in End-of-Year Spending Package
The Medical Imaging & Technology Alliance (MITA) today commended lawmakers for including a permanent repeal of the medical device tax in the recently announced year-end government funding package. The inclusion of repeal within the agreement is the result of broad bipartisan support in both... - December 17, 2019 - Medical Imaging and Technology Alliance
ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge,... - December 11, 2019 - ALS Therapy Development Institute
Be the Difference Foundation to Raise Money for 12 Ovarian Cancer Clinical Trials
Be The Difference Foundation has launched its 12 Clinical Trials for Christmas campaign, an effort to provide clinical trials for 12 women battling ovarian cancer. Be The Difference Foundation’s 12 Clinical Trials for Christmas campaign not only raises money to cover the cost of a clinical... - December 11, 2019 - Be the Difference Foundation
New World Medical Named Among the Inland Empire Top Workplaces
New World Medical, a global medical company focused on glaucoma treatment, has been listed in the Inland Empire Top Workplaces 2019 organized by Inland News Group. The Top Workplaces list is based on an anonymous survey administered by the Energage platform, which measures several aspects of... - December 09, 2019 - New World Medical
The ASAcampus Team Takes Part in XENOGRISS, One of the Italian Experiments by the Italian Space Agency, for the ESA Beyond Mission
The Space-X 19 was launched at 12:29 EST on December 5 last; on-board it carries some scientific experiments that will be undertaken on the International Space Station during the Beyond Mission, led by the Italian astronaut Luca Parmitano from the European Space Agency. - December 08, 2019 - ASA srl
CureTalks@UCSFCancer Puts Patients at the Center, with Live and Archivable Internet Radio Talk Shows Featuring Patients, Advocates and Leading Oncology Researchers
CureTalks, an internet radio and video podcasting service of TrialX, features leading physicians in conversation with patients, caregivers, and patient advocates. The University of California, San Francisco Helen Diller Family Comprehensive Cancer Center (HDFCCC) is the most recent institution to... - December 04, 2019 - TrialX
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Dr. Amishi Desai Joins New York Cancer & Blood Specialists in Suffolk
New York Cancer & Blood Specialists (NYCBS) is proud to announce Amishi Desai, MD to its team. Dr. Desai is board-certified in hematology-oncology, as well as internal medicine. As such, she covers a full scope of services, while also maintaining a particular interest in lung cancer. In... - December 03, 2019 - New York Cancer & Blood Specialists
CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference
CLL Society co-founder and Medical Director Dr. Brian Koffman will present research results of the society's innovative telemedicine program at the prestigious American Society of Hematology annual meeting in early December. The program provides patients and caregivers access to HIPPA-compliant second opinions from renowned specialists in chronic lymphocytic leukemia (CLL), the most common adult blood cancer. - November 30, 2019 - CLL Society
Rose Center for Bariatrics Recognized Among the Top 5% in Nation for Bariatric Surgery
Rose Medical Center receives multiple bariatric surgery top honors from Healthgrades. - November 29, 2019 - Rose Medical Center
Dr. Varghese Cherian Joins New York Imaging Specialists
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton. Dr. - November 28, 2019 - New York Imaging Specialists
New York Imaging Specialists Announces Grand Opening in Port Jefferson Station
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776. New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes... - November 28, 2019 - New York Imaging Specialists
Kidney Care Community Encouraged by New USRDS Data, Stresses the Need for Continued Improvement
The latest United States Renal Data System (USRDS) report underscores the need to expand education and early detection efforts to improve health outcomes. - November 27, 2019 - Kidney Care Partners
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019 - ALS Therapy Development Institute
Varicose Veins Doctors Provide Minimally Invasive Treatment Procedures for Varicose Veins
Varicose Veins Doctors is a reputable vein treatment center in Manhattan, NY. The clinic has gained a reputation for its exceptional patient care and a wide range of effective treatment options for vein diseases. Their teams of experts use state-of-the-art equipment to perform complex procedures for pain relief. - November 20, 2019 - Varicose Veins Doctors
Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
Bold Health Partners with the University of Pennsylvania for Clinical Trial of Its Zemedy IBS App
The School of Arts and Science of the prestigious University of Pennsylvania has tendered a public invitation for suitable individuals to participate in a waitlist randomised control trial aimed at investigating the potential benefits of the Zemedy mobile app in patients with Irritable Bowel... - November 13, 2019 - Bold Health
Global Regenerative Group Enters Into Distribution Partnership with Aurafix & Remodem
Global Regenerative Group, a proven company in the field of medicine and innovation, is pleased to announce partnerships with Remodem and Aurafix. - November 09, 2019 - Global Regenerative Group
ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
OrthoNeuro Spine Surgeon Performs the First Robotics-Assisted Minimally Invasive 2-Level Lumbar Interbody Fusion Surgery in Central Ohio at Mt. Carmel St. Ann’s Hospital
Dr. Ying Chen, OrthoNeuro Neurosurgeon, completed the first robotics-assisted minimally invasive 2-level interbody fusion surgery in Central Ohio. This surgical milestone occurred on October 28, 2019 using the Globus Excelsius GPS Robotic Navigation System. - November 06, 2019 - OrthoNeuro
Cephasonics Ultrasound Awarded Competitive Grant from the National Science Foundation for Ultrasound Research
Cephasonics Ultrasound has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant to conduct research and development (R&D) toward developing a new computational architecture for AI-enabled Ultrafast Frameforming ultrasound systems (UFFFI) - November 04, 2019 - Cephasonics Ultrasound
ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
NYCBS Welcomes Dr. Keith Brunckhorst to Its Oncology Team
Keith R. Brunckhorst, MD is a talented physician who is board-certified in medical oncology and hematology. He is experienced and well versed in the most cutting-edge cancer technology, with an impeccable work history and education. For Dr. Brunckhorst, patients come first. He pledges to treat each... - October 17, 2019 - New York Cancer & Blood Specialists
NextHealth’s Executive Advisory Council Tackles How Payers Are Measuring and Optimizing Their Clinical Portfolios for Reduced Costs and Improved Outcomes
Analytics shine a spotlight on the initiatives that deliver value and how to integrate resulting insights into workflow. - October 17, 2019 - NextHealth Technologies
Sky Ridge Medical Center Awarded Thrombectomy-Capable Stroke Center Certification from The Joint Commission
Sky Ridge Medical Center has earned The Joint Commission’s Gold Seal of Approval® and the American Stroke Association’s Heart-Check mark as a Thrombectomy-Capable Stroke Center. - October 16, 2019 - Sky Ridge Medical Center
Aciont Issued Key Patent Covering the Novel Design of the Visulex Ocular Drug Delivery Device
Aciont was issued a U.S. patent that covers an important aspect of the novel design of its main Visulex ocular drug delivery system which has been tested for safety and efficacy in its lead clinical program under U.S. IND. - October 12, 2019 - Aciont Inc.
IDI Consulting Raises Blood Cancer Awareness & Funds Through Light The Night Walk
Local IT consulting company participates in fourth year of fundraising efforts for The Leukemia & Lymphoma Society. - October 12, 2019 - IDI Consulting
HCA Healthcare/HealthONE’s Swedish Medical Center First in Colorado to Offer Minimally Invasive Surgery to Remove Blood Clot from Brain
New Procedure Quickly Removes Blood from Brain after Intracerebral Hemorrhage. - October 11, 2019 - Swedish Medical Center
NYCBS' CEO to Receive Humanitarian of the Year Award from the American Red Cross
New York Cancer & Blood Specialists (NYCBS) announced that their own CEO, Jeff Vacirca, MD, will be the 2019 American Red Cross Greater New York Region’s Humanitarian Award recipient. Dr. Vacirca will be honored on Wednesday, Oct. 16, 2019 at the 2019 Heroes Among Us Gala at the Ziegfeld... - October 10, 2019 - New York Cancer & Blood Specialists
ZKSciences Plant Growth Accelerator Technology Enters Formal Trials
ZKSciences has started formal third-party plant trials of its patent-pending ZK GrowFactor(TM) plant growth accelerator technology. ZK GrowFactor is a family of engineered zeolites that have shown phenomenal potential for increasing plant yields, improving the appearance of flowers and ornamental... - October 03, 2019 - ZKsciences
Tickets Now on Sale for The 19th Annual Dancing for Diabetes Show
Dancing for Diabetes has raised nearly half a million dollars for Type 1 Diabetes research. The 19th Annual Dancing for Diabetes Show will be held on Saturday, November 9 at the Bob Carr Theater in Orlando, Florida. - October 03, 2019 - Dancing for Diabetes
Swedish Medical Center First in Colorado to Use New Treatment for Brain Aneurysms
Rocky Mountain region neuroscience center of excellence introduces technology to treat challenging aneurysms with positive benefits for patients. - September 30, 2019 - Swedish Medical Center
VOS Digital Media Group Now Offering Health Content from Harvard Health Publishing
Harvard Health Publishing Provides Expert Health Information and Advice. - September 24, 2019 - Icaro Media Group
APTQI Urges CMS to Protect Seniors from Debilitating Falls by Preserving Medicare Reimbursement for Physical Therapy
Recognizing Falls Prevention Awareness Day 2019, APTQI is advocating for greater patient access to fall prevention tools such as manual and exercise therapy. - September 23, 2019 - Alliance for Physical Therapy Quality and Innovation
National Institutes of Health Selects Eva Garland Consulting to Lead Applicant Assistance Program
EGC will provide expert coaching to hundreds of companies seeking NIH SBIR/STTR funding. - September 23, 2019 - Eva Garland Consulting
A Year After the Launch of Ayushman Bharat Yojana; Medical Devices, Pharma Industries in India Expected to Benefit Substantially: Whitepaper by Nexdigm (SKP)
In 2017, the Indian Government introduced a National Health Policy (Ayushman Bharat or Healthy India) that aims to offer universal health coverage and provide the foundation for equitable healthcare. In this paper, SKP examines the potential of the NHPS and attempts to study the impact it creates on healthcare accessibility along with opportunities created for various stakeholders in the industry. - September 22, 2019 - Nexdigm
DNAtix Launches Free Anonymous Genetic Vault
Digital DNAtix Ltd., the Israeli cyber genetics startup, has announced the first free anonymous genetic vault service. DNAtix developed the Cyber Genetics Smart Platform for Digital Genetics. Lack of privacy is currently a barrier for so many people who want to have their DNA tested but are afraid to give their genetic data away. As of today anyone can anonymously upload their raw file from 23&Me and Ancestry.com onto the DNAtix platform. - September 17, 2019 - Digital DNAtix Ltd.